Pearl Grimes, MD: The Psychological Impact of Vitiligo and Advancements in Treatment
Pearl Grimes, MD, Director of of Vitiligo and Pigmentation Institute of Southern California and Clinical Professor of Dermatology at UCLA discusses exciting advancements in therapy in hopes of finding JAK inhibitors that address stabilization, repigmentation and maintenance for vitiligo. In addition, Dr. Grimes reviews the emotional impact this disease has on patients.
Raj Chovatiya, MD, PhD: Explaining the Mechanisms and Advantages of JAK Inhibitors
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses the newly available JAK inhibitors for use in a variety of dermatological conditions. Dr. Chovatiya reviews how JAK inhibitors work differently from other agents to reduce inflammation and the benefits that they can have for certain patient populations.
Journal Review: Valerie Callender
Valerie Callender, MD, is the Founder and Medical Director of the Callender Dermatology & Cosmetic Center, and is known for her sensitive and cutting-edge approach to the management of hair loss in women. Here, Dr. Callender discusses the article, “A Prospective Six-month Single-blind Study Evaluating Changes in Hair Growth and Quality Using a Nutraceutical Supplement in Men and Women of Diverse Ethnicities,” which was published in the January 2022 issue of the Journal of Clinical and Aesthetic Dermatology.
Journal Review: Nanette Silverberg (Full Manuscript)
Nanette Silverberg, MD, a Clinical Professor of Pediatrics and Dermatology at the Icahn School of Medicine at Mount Sinai in New York, New York, provides an overview of an article published in the Journal of Drugs in Dermatology regarding the use of a 308 nm laser for the treatment of pediatric vitiligo.
Scott Dinehart: Hedgehog Inhibitors
Dr. Dinehart discusses tips for reducing side effects while treating patients with hedgehog inhibitors, such as reduced dosing frequency and the concurrent use of L-carnitine.